KMID : 0614620220800060247
|
|
Korean Journal of Gastroenterology 2022 Volume.80 No. 6 p.247 ~ p.253
|
|
Treatment of Acid-related Diseases Using Potassium-competitive Acid Blockers
|
|
Choi Yoon-Jin
|
|
Abstract
|
|
|
Proton pump inhibitors (PPIs) have several limitations to their efficacy including insufficient acid suppression, slow onset of action, and variable efficacy among patients due to CYP2C19 metabolism. Potassium-competitive acid blockers inhibit H+-K+-ATPase in a reversible and K+-competitive manner, are novel acid suppressive drugs with rapid onset of action, meal independence, and prolonged control of intragastric acidity compared to PPIs. Potassium-competitive acid blockers exhibited non-inferior therapeutic efficacies on reflux esophagitis, gastric ulcers, and Helicobacter pylori eradication. The review is focused on the unmet needs across the acid-related diseases and recent updates on clinical studies using vonoprazan and tegoprazan.
|
|
KEYWORD
|
|
Gastric acid, Gastroesophageal reflux, Peptic ulcer, Helicobacter pylori
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|